A phase 2 study of DACRA in People with obesity and osteoarthritis (OA)
Latest Information Update: 15 Oct 2024
Price :
$35 *
At a glance
- Drugs KBP 042 (Primary)
- Indications Obesity; Osteoarthritis
- Focus Therapeutic Use
- 15 Oct 2024 New trial record